Copyright Reports & Markets. All rights reserved.

Global Triptorelin Drug Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Triptorelin Drug Market Overview

      • 1.1 Product Overview and Scope of Triptorelin Drug
      • 1.2 Triptorelin Drug Segment by Type
        • 1.2.1 Global Triptorelin Drug Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 3.75 mg Vial
        • 1.2.3 11.25 mg Vial
        • 1.2.4 22.5 mg Vial
      • 1.3 Triptorelin Drug Segment by Application
        • 1.3.1 Triptorelin Drug Consumption Comparison by Application (2014-2025)
        • 1.3.2 Advanced prostate cancer
        • 1.3.3 Endometriosis
        • 1.3.4 Uterine fibroids
        • 1.3.5 Precocious puberty
      • 1.4 Global Triptorelin Drug Market by Region
        • 1.4.1 Global Triptorelin Drug Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Triptorelin Drug Market Size
        • 1.5.1 Global Triptorelin Drug Revenue (2014-2025)
        • 1.5.2 Global Triptorelin Drug Production (2014-2025)

      2 Global Triptorelin Drug Market Competition by Manufacturers

      • 2.1 Global Triptorelin Drug Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Triptorelin Drug Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Triptorelin Drug Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Triptorelin Drug Production Sites, Area Served, Product Types
      • 2.5 Triptorelin Drug Market Competitive Situation and Trends
        • 2.5.1 Triptorelin Drug Market Concentration Rate
        • 2.5.2 Triptorelin Drug Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Triptorelin Drug Production Market Share by Regions

      • 3.1 Global Triptorelin Drug Production Market Share by Regions
      • 3.2 Global Triptorelin Drug Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Triptorelin Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Triptorelin Drug Production
        • 3.4.1 North America Triptorelin Drug Production Growth Rate (2014-2019)
        • 3.4.2 North America Triptorelin Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Triptorelin Drug Production
        • 3.5.1 Europe Triptorelin Drug Production Growth Rate (2014-2019)
        • 3.5.2 Europe Triptorelin Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Triptorelin Drug Production (2014-2019)
        • 3.6.1 China Triptorelin Drug Production Growth Rate (2014-2019)
        • 3.6.2 China Triptorelin Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Triptorelin Drug Production (2014-2019)
        • 3.7.1 Japan Triptorelin Drug Production Growth Rate (2014-2019)
        • 3.7.2 Japan Triptorelin Drug Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Triptorelin Drug Consumption by Regions

      • 4.1 Global Triptorelin Drug Consumption by Regions
      • 4.2 North America Triptorelin Drug Consumption (2014-2019)
      • 4.3 Europe Triptorelin Drug Consumption (2014-2019)
      • 4.4 China Triptorelin Drug Consumption (2014-2019)
      • 4.5 Japan Triptorelin Drug Consumption (2014-2019)

      5 Global Triptorelin Drug Production, Revenue, Price Trend by Type

      • 5.1 Global Triptorelin Drug Production Market Share by Type (2014-2019)
      • 5.2 Global Triptorelin Drug Revenue Market Share by Type (2014-2019)
      • 5.3 Global Triptorelin Drug Price by Type (2014-2019)
      • 5.4 Global Triptorelin Drug Production Growth by Type (2014-2019)

      6 Global Triptorelin Drug Market Analysis by Applications

      • 6.1 Global Triptorelin Drug Consumption Market Share by Application (2014-2019)
      • 6.2 Global Triptorelin Drug Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Triptorelin Drug Business

      • 7.1 Allergan
        • 7.1.1 Allergan Triptorelin Drug Production Sites and Area Served
        • 7.1.2 Triptorelin Drug Product Introduction, Application and Specification
        • 7.1.3 Allergan Triptorelin Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Debiopharm Group
        • 7.2.1 Debiopharm Group Triptorelin Drug Production Sites and Area Served
        • 7.2.2 Triptorelin Drug Product Introduction, Application and Specification
        • 7.2.3 Debiopharm Group Triptorelin Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Ipsen
        • 7.3.1 Ipsen Triptorelin Drug Production Sites and Area Served
        • 7.3.2 Triptorelin Drug Product Introduction, Application and Specification
        • 7.3.3 Ipsen Triptorelin Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Xbrane Biopharma
        • 7.4.1 Xbrane Biopharma Triptorelin Drug Production Sites and Area Served
        • 7.4.2 Triptorelin Drug Product Introduction, Application and Specification
        • 7.4.3 Xbrane Biopharma Triptorelin Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Chengdu Tiantaishan pharmaceutical
        • 7.5.1 Chengdu Tiantaishan pharmaceutical Triptorelin Drug Production Sites and Area Served
        • 7.5.2 Triptorelin Drug Product Introduction, Application and Specification
        • 7.5.3 Chengdu Tiantaishan pharmaceutical Triptorelin Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Arbor Pharmaceuticals
        • 7.6.1 Arbor Pharmaceuticals Triptorelin Drug Production Sites and Area Served
        • 7.6.2 Triptorelin Drug Product Introduction, Application and Specification
        • 7.6.3 Arbor Pharmaceuticals Triptorelin Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Ferring
        • 7.7.1 Ferring Triptorelin Drug Production Sites and Area Served
        • 7.7.2 Triptorelin Drug Product Introduction, Application and Specification
        • 7.7.3 Ferring Triptorelin Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served

      8 Triptorelin Drug Manufacturing Cost Analysis

      • 8.1 Triptorelin Drug Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Triptorelin Drug
      • 8.4 Triptorelin Drug Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Triptorelin Drug Distributors List
      • 9.3 Triptorelin Drug Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Triptorelin Drug Market Forecast

      • 11.1 Global Triptorelin Drug Production, Revenue Forecast
        • 11.1.1 Global Triptorelin Drug Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Triptorelin Drug Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Triptorelin Drug Price and Trend Forecast (2019-2025)
      • 11.2 Global Triptorelin Drug Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Triptorelin Drug Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Triptorelin Drug Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Triptorelin Drug Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Triptorelin Drug Production, Revenue Forecast (2019-2025)
      • 11.3 Global Triptorelin Drug Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Triptorelin Drug Consumption Forecast (2019-2025)
        • 11.3.2 Europe Triptorelin Drug Consumption Forecast (2019-2025)
        • 11.3.3 China Triptorelin Drug Consumption Forecast (2019-2025)
        • 11.3.4 Japan Triptorelin Drug Consumption Forecast (2019-2025)
      • 11.4 Global Triptorelin Drug Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Triptorelin Drug Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Triptorelin, the active substance of Decapeptyl®/Trelstar®/Pamorelin®/Triptodur®, is a GnRH agonist analogue. An agonist is a chemical that binds to a receptor of a cell and triggers a response by that cell. Triptorelin decreases the serum testosterone to castrate levels (estradiol in females).

        The global Triptorelin Drug market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Triptorelin Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Triptorelin Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Allergan
        Debiopharm Group
        Ipsen
        Xbrane Biopharma
        Chengdu Tiantaishan pharmaceutical
        Arbor Pharmaceuticals
        Ferring
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        3.75 mg Vial
        11.25 mg Vial
        22.5 mg Vial

        Segment by Application
        Advanced prostate cancer
        Endometriosis
        Uterine fibroids
        Precocious puberty

        Buy now